Vitamin prices across key categories are experiencing overall stability, with only minor fluctuations reported in select regions. Contract coverage for the first half of the year is robust, reflecting balanced supply and demand dynamics. Market activity in the USA, China, and Europe highlights localized trends, but broader pricing remains steady.
In partnership with Feed Additive Prices
Vitamin E 50%
Overall, while spot prices in the USA have seen a slight increase, stability prevails in other regions. In China, there has been some recent upward pressure on prices along with multiple attempts by suppliers to adjust from the low price levels. Nonetheless, the supply and demand dynamics appear to be relatively well-balanced, leading to price stability in most markets, with a slightly firmer tone to it. Contracts for the first quarter and the majority of the second quarter have been secured, with indications of limited coverage extending into the third quarter.
Vitamin A 1000
Vitamin A1000 prices remain steady, with no significant fluctuations observed outside of China following the Chinese New Year. The United States is experiencing a slight tightening in supply due to concerns surrounding the quality of a new Chinese supplier, prompting buyers to revert to established sources. However, availability in other regions appears to be ample, and prices continue to hold steady. Contracts for the first quarter and a substantial portion of the second quarter are already in place.
Vitamin D3 500
As prices have recently dipped but remain relatively high, several regions have seen a decrease in material imports. This has created a more balanced supply and demand dynamic that has contributed to price stability, although with a weakish tone to it. While Q1 contracts have already been settled, coverage for Q2 remains low as buyers are adopting a cautious approach and primarily opting for spot purchases.
Vitamin B2 80%
Slightly firmer prices were recently reported in Europe, as one of the main manufacturers said to have supply issues. Apart from that, supply is said to be okay in most regions, and prices show an overall stable tone. Q1 and a good portion of Q2 are contracted.
D-Calpan
Market activity is currently calm, with prices remaining mostly stable or experiencing slight declines still in some regions. Supply levels are reported to be good, and suppliers are keen to maintain their market presence. Q1 is fully contracted, and because of the low price, a good portion of Q2 is contracted as well.
Vitamin B3
The market has stabilised following a period of modest price increases and active trading. Although suppliers still aim to move away from the current relatively low price levels. Prices have recently been slightly higher across all regions, but stability has returned. Contracts for the first quarter have been finalised, and a considerable amount of the second quarter is now also secured.
Biotin
Recently, the prices for biotin came down a bit after a long and steady period. Although suppliers would actually like to see prices go up, the market dynamics have resulted in a slight decline. A good portion of Q2 is contracted by now, and the market is relatively quiet.
Vitamin C 35% mono
The current demand for vitamin C products remains relatively low, resulting in stable pricing at this time. Market participants are not anticipating any significant changes until new demand potentially emerges in the second or third quarter. Q1 and a substantial portion of Q2 have already been contracted.
